Cognitive impairment in diabetes mellitus and hypertension, a possibility of correction by Khairullin I. et al.
Nevrologiya, Neiropsikhiatriya, Psikhosomatika 2016 vol.8 N3, pages 48-52
Cognitive impairment in diabetes mellitus and
hypertension, a possibility of correction
Khairullin I., Esin R., Esin O.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
Objective: to evaluate cognitive functions in patients with type 2 diabetes mellitus (DM2) and
hypertension and the efficacy of Ginkgo biloba extract Egb 761®. Patients and methods: 120
patients with DM2 and 50 hypertensive patients with no complications or a history of stroke
and/or  myocardial  infarction,  without  active complaints  of  hypomnesia  and other  cognitive
functions were examined. The exclusion criteria were prior stroke and/or myocardial infarction;
clinically significant diseases of the peripheral arteries and major arteries of the head; DM2
decompensation;  glomerular  filtration rate <60 ml/min;  proliferative retinopathy;  and other
endocrine diseases. The investigators used the following methods for the evaluation of cognitive
functions: the Mini-Mental State Examination, the Montreal Cognitive Assessment, and the hand-
eye coordination test (Parts A and B). Results and discussion: 85% of the patients with DM2
were found to have cognitive impairments (CI): disorders of attention, short-term memory, and
thinking speed. Out of them, 82.5% had moderate CI and 2.5% had dementia. 30% of the
hypertensive patients were diagnosed as having moderate CIs and 10% had dementia. At the
same  time,  the  degree  of  CI  was  higher  in  the  patients  with  MD2  than  in  those  with
hypertension. The use of Egb 761® 240 mg/day for 3 months had a statistically significant
positive impact on cognitive functions (improvements in short-term memory, concentration, and
thinking speed) and everyday activity. Conclusion: The authors consider that CIs are the first
sign of encephalopathy in DM2. It is also noted that DM2 has a more pronounced impact on
cognitive functions than hypertension. Egb 761® can be used as an effective drug to treat CI in
these diseases.
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